AbbVie Inc.
ABBV
$245.25
$1.450.60%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.61B | 695.00M | 1.82B | 186.00M | 938.00M |
| Total Depreciation and Amortization | 1.88B | 1.94B | 1.99B | 2.06B | 2.05B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 661.00M | 3.12B | 1.89B | 3.52B | 2.73B |
| Change in Net Operating Assets | -2.72B | -1.92B | -473.00M | 1.25B | -562.00M |
| Cash from Operations | 3.44B | 3.83B | 5.22B | 7.02B | 5.15B |
| Capital Expenditure | -322.00M | -265.00M | -329.00M | -381.00M | -269.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -824.00M | -266.00M | -1.16B | -2.80B | -940.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -51.00M | -43.00M | 27.00M | -81.00M | 28.00M |
| Cash from Investing | -1.20B | -574.00M | -1.46B | -3.26B | -1.18B |
| Total Debt Issued | 0.00 | 7.99B | -500.00M | 241.00M | 3.96B |
| Total Debt Repaid | -2.00B | -2.50B | -799.00M | -2.02B | -3.75B |
| Issuance of Common Stock | -- | -- | 48.00M | 63.00M | -- |
| Repurchase of Common Stock | -9.00M | -1.49B | -3.00M | -4.00M | -12.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.07B | -3.09B | -2.91B | -2.91B | -2.91B |
| Other Financing Activities | 25.00M | 2.00M | -1.00M | 37.00M | 3.00M |
| Cash from Financing | -5.05B | 919.00M | -4.17B | -4.59B | -2.71B |
| Foreign Exchange rate Adjustments | -7.00M | -12.00M | 11.00M | -8.00M | 30.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.82B | 4.16B | -400.00M | -838.00M | 1.29B |